Closed Door
RoomsLibraryToursPeopleCompareSourcesAbout
Gemini
All Roomspharma · 3 pairs
The addiction scapegoat

Purdue Pharma & The Sacklers

Purdue Pharma transformed OxyContin into a blockbuster narcotic by assuring physicians that the risk of addiction was 'under 1%' due to a patented time-release coating. When public health data showed widespread overdose deaths in rural Appalachia and beyond, the Sackler family's internal reaction was not to reformulate or pull the drug, but to scapegoat the victims. Richard Sackler ordered staff to 'hammer on the abusers in every way possible', while marketing executives designed sales contests rewarding sales reps with luxury resort trips for pressing doctors to prescribe massive 80mg doses.

Read this room in full-screen mode →

Unsealed Divergence Pairs (3)

Chronological & Evasion Order
values-afterpharma·2001

Hammer on the abusers

Full-screen reader
Public Register2001

Purdue Pharma Public Relations

press release & patient brochure · National Pain Management Campaign

“OxyContin provides 12 hours of smooth, continuous pain relief. Clinical studies demonstrate that the risk of addiction in legitimate pain patients is exceedingly rare (under 1%).”
Original ↗
Private ArtifactFebruary 2001

Richard Sackler

Co-Chairman and Senior VP, Purdue Pharma · Confidential email to Purdue executives

“We have to hammer on the abusers in every way possible. They are the culprits and the problem. They are reckless criminals who steal our product and ruin it for legitimate sufferers.”
Docket ↗
The Split:Purdue aggressively marketed OxyContin as non-addictive to doctors. When devastating community addiction exploded, Richard Sackler sent private emails instructing staff to blame and criminalize the victims: 'hammer on the abusers... they are reckless criminals.'
The Tell:When an institution creates a lethal defect and pivots to blaming the moral degeneracy of the victim, look for an executive memo directing the scapegoating.
Pipe: courtUnredacted Massachusetts Attorney General complaint (Maura Healey).
Next pair →
advertorialpharma·1999 / unsealed 2002

Pushing 80mg dosage for sales bonuses

Full-screen reader
Public Register2002

Purdue Clinical Guidelines

physician training literature · Partners Against Pain Educational Portal

“Dosing decisions must be individualized strictly according to patient pain severity and medical judgment, with safety and clinical titration leading the way.”
Original ↗
Private Artifact1999

Purdue National Sales Leadership

internal sales incentive program · Internal Sales Contest Memo ('Toppers' Incentive Program)

“Target doctors who prescribe 20mg and push them to titrate up to 80mg and 160mg tablets. The 80mg dose is where our highest profit margins live. Sales reps who convert low-dose prescribers will receive double bonus points and luxury resort trips.”
Docket ↗
The Split:In clinical literature, Purdue claimed dosage was governed solely by individualized medical need. In sales compensation memos, reps were given cash incentives specifically to pressure doctors into prescribing massive 80mg doses to maximize profit margins.
The Tell:Follow the bonus compensation structure: whatever medical ethics profess in the pamphlet, sales reps will push whatever dosage generates the highest luxury-trip multiplier.
Pipe: courtUnsealed in state and federal opioid multidistrict litigation (MDL 2804).
Next pair →
testimony-gappharma·2002 / unsealed 2007

Mapping corrupt pharmacies and pill mills

Full-screen reader
Public Register2007

Purdue Executives Sworn Testimony

congressional testimony · US Senate Judiciary Hearing on Prescription Drug Abuse

“Purdue had no insight or mechanism to know whether legitimate pharmacies were being utilized for illicit diversion. When we discovered suspicious prescribers, we acted promptly.”
Original ↗
Private Artifact2002

Purdue Internal Security & Sales Audits

internal compliance records · Internal Diversion Database Entries

“Doctor X in Myrtle Beach is prescribing hundreds of thousands of 80mg tablets per month with cash-only queues around the block. Sales reps noted the clinic is a blatant pill mill, yet orders were approved and deliveries expedited to meet quarterly budget targets.”
Docket ↗
The Split:Under oath to the Senate, executives claimed they had no ability to detect rogue doctors. Their own internal computer databases explicitly tracked known pill mills with lines out the door, while management expedited supply to make quarterly revenue targets.
The Tell:When a distributor swears under oath that it lacked data to detect illegal volume, check its internal sales leaderboard: the rogue customers were usually ranked number one.
Pipe: courtDisclosed in UCSF Opioid Industry Documents Archive.